Malignant Tumors Occurring after Treatment of Aplastic Anemia

1993464 citationsJournal Articlebronze Open Access

Authors

Gèrard Socié · Hôpital Saint-Louis

M. Henry‐Amar · Institut Gustave Roussy

Andrea Bacigalupo · Ospedale Policlinico San Martino

Jill Hows · Southmead Hospital

André Tichelli · Kantonsspital Baselland

Per Ljungman · Karolinska Institutet

Shaun R. McCann ·

Abstract

Survivors of aplastic anemia are at high risk for subsequent malignant conditions. Myelodysplastic syndrome and acute leukemia tend to follow immunosuppressive therapy, whereas the incidence of solid tumors is similar after immunosuppression and after bone marrow transplantation.

Topics & Keywords

Acute Myeloid Leukemia Research Hematopoietic Stem Cell Transplantation Vascular Tumors and Angiosarcomas

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 329, Issue 16, pp. 1152-1157

DOI: 10.1056/nejm199310143291603

Field-Weighted Citation Impact: 7.92